Capricor Therapeutics, Inc. (CAPR)
6.71
-0.56
(-7.70%)
USD |
NASDAQ |
Oct 16, 16:00
6.73
+0.02
(+0.30%)
After-Hours: 20:00
Capricor Therapeutics Net Income (TTM) : -129.42M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -129.42M |
| March 31, 2026 | -114.59M |
| December 31, 2025 | -105.04M |
| September 30, 2025 | -81.99M |
| June 30, 2025 | -69.98M |
| March 31, 2025 | -55.06M |
| December 31, 2024 | -40.47M |
| September 30, 2024 | -34.11M |
| June 30, 2024 | -27.95M |
| March 31, 2024 | -24.31M |
| December 31, 2023 | -22.29M |
| September 30, 2023 | -29.25M |
| June 30, 2023 | -29.23M |
| March 31, 2023 | -28.97M |
| December 31, 2022 | -29.02M |
| September 30, 2022 | -27.49M |
| June 30, 2022 | -25.05M |
| March 31, 2022 | -22.69M |
| December 31, 2021 | -20.02M |
| September 30, 2021 | -18.01M |
| June 30, 2021 | -17.99M |
| March 31, 2021 | -16.72M |
| December 31, 2020 | -13.66M |
| September 30, 2020 | -10.95M |
| June 30, 2020 | -8.645M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.207M |
| December 31, 2019 | -7.642M |
| September 30, 2019 | -9.432M |
| June 30, 2019 | -11.96M |
| March 31, 2019 | -14.04M |
| December 31, 2018 | -15.19M |
| September 30, 2018 | 0.374M |
| June 30, 2018 | 1.775M |
| March 31, 2018 | 2.426M |
| December 31, 2017 | 2.431M |
| September 30, 2017 | -14.39M |
| June 30, 2017 | -16.99M |
| March 31, 2017 | -18.21M |
| December 31, 2016 | -18.81M |
| September 30, 2016 | -17.63M |
| June 30, 2016 | -15.21M |
| March 31, 2016 | -13.65M |
| December 31, 2015 | -12.86M |
| September 30, 2015 | -11.44M |
| June 30, 2015 | -10.07M |
| March 31, 2015 | -8.482M |
| December 31, 2014 | -6.217M |
| September 30, 2014 | -11.75M |
| June 30, 2014 | -10.56M |
| March 31, 2014 | -9.620M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ARS Pharmaceuticals, Inc. | -215.43M |
| SELLAS Life Sciences Group, Inc. | -32.46M |
| Sionna Therapeutics, Inc. | -97.38M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Cytokinetics, Inc. | -894.00M |